News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zydus Cadila Is Fourth Indian Drugmaker To Exit Japanese Market



1/28/2014 8:02:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cadila Healthcare Ltd on Monday said it has decided to close its Japanese subsidiary set up in 2006 to tap the world’s second-largest pharmaceutical market. “The company has recently completed portfolio and strategy review of its business and has decided to exit from its business in Japan, which is through a 100% subsidiary company,” Cadila Healthcare said in a statement to the stock exchanges on Monday, without specifying a reason. Cadila, also known as Zydus Cadila, set up Zydus Pharma Inc. in 2006 to tap Japan’s emerging market for copycat drugs.

Help employers find you! Check out all the jobs and post your resume.

Read at Live Mint
Read at Business Standard
Read at EconomicTimes
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES